Axonic
Neurostimulation research and development for medical treatments of pathologies not adequately addressed by current therapies
Highlights
- New on EvolcAdded 2026-11-14
About Axonic
Axonic develops neurostimulation technologies and medical-device projects for conditions that are not adequately treated by current approaches. Its research includes neural interfaces using graphene-coated stimulation electrodes.
The company works with research institutions, university hospital professors and international companies. Axonic is based in Vallauris, France, and is a subsidiary of the MXM group.
Product: Research and development of neurostimulation technologies and medical devices.
Jobs at Axonic
More health & medtech companies
Axorus
Develops a non-invasive photoacoustic contact lens for people with retinal blindness, including dry AMD and retinitis pigmentosaNew on EvolcAz-Vet
Veterinary clinic providing care for companion animals in Saint-Clément near Sens, FranceNew on EvolcAzmed
AI software for medical imaging that supports radiology teams with X-ray and CT analysisAzoth Systems
Decompression safety monitoring services for professional divers, hyperbaric operators, scientists and training centresNew on EvolcAzur Health Science
Medical writing and regulatory support for healthcare, research and medical organisationsNew on EvolcRemote-friendlyAzur Sante Plus
Home care and household services for seniors, people with disabilities and families in the Alpes-Maritimes
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.